Corporate roadshows pile up as ECB keeps lid on spreads

By Mike Turner
06 Nov 2019

A steady flow of deals is running through the investment grade corporate bond pipeline and out into the market. This is expected to become a deluge before long, as investors’ inboxes are filling up with roadshow invitations.

German pharmaceutical company Bayer is the latest to join the queue, having announced a mandate for a dual tranche euro hybrid capital issue on Wednesday with maturities of 60 non-call 5.5 years and non-call eight (see separate story).

“It was expected,” said an investor, “but it’s still ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.